跳至主要内容
临床试验/CTRI/2020/06/026102
CTRI/2020/06/026102已完成未知

Estimation Of Matrix Metalloproteinase(MMP)9 In Saliva Among Patients With Oral Leukoplakia,Oral Sub Mucous Fibrosis And Controls

Akshaya0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Individuals willing to take part in the study
  • Subjects who are clinically and histopathologically diagnosed with Oral leukoplakia.
  • Subjects who are clinically diagnosed with OSMF.
  • Healthy individuals free from systemic illness.
  • Healthy individuals free from systemic illness and willing to take part in the study are included in control group.

排除标准

  • 1.Patients with oral cancer
  • 2.Previously treated potentially malignant disorders like oral leukoplakia, OSMF and lichen planus.
  • 3.Having history of significant psychosis/ cognitive impairment
  • 4.Patients with salivary gland disorders causing xerostomia.
  • 5.Patient with acute illness or terminally ill patients.
  • 6.Pregnant women and lactating mother.
  • 7.Patients with systemic diseases which include diabetes, rheumatoid arthritis and hypertension which alter MMP 9 levels.
  • 8.Patients on long term steroid therapy.

研究者

发起方
Akshaya

相似试验